Connor C. Call

Connor C. Call

Auto-generated profile, based on publicly available information

Connor C. Call

Department of Chemical Engineering, Stanford University, Stanford, CA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2025 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
XZXiaowei Zhang
Xiaowei Zhang
LFLuis Santiago Mille Fragoso
Luis Santiago Mille Fragoso
KKK. Eerik Kaseniit
K. Eerik Kaseniit
ALArden P. Lee
Arden P. Lee
MZMeng Zhang
Meng Zhang
XGXiaojing J. Gao
Xiaojing J. Gao

22 January 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CACarlos A. Aldrete
Carlos A. Aldrete
CCConnor C. Call
Connor C. Call
LSLucas E. Sant’anna
Lucas E. Sant’anna
AVAlexander E. Vlahos
Alexander E. Vlahos
JPJimin Pei
Jimin Pei
XGXiaojing J. Gao
Xiaojing J. Gao
Synthetic circuits that regulate protein secretion in human cells could support cell-based therapies by enabling control over local environments. While protein-level circuits enable such potential clinical applications, featuring orthogonality and compactness, their non-human origin poses a potential immunogenic risk. Here, we developed Humanized Drug Induced Regulation of Engineered CyTokines (hDIRECT) as a platform to control cytokine activity exclusively using human-derived proteins. We sourced a specific human protease and its FDA-approved inhibitor. We engineered cytokines (IL-2, IL-6, and IL-10) whose activities can be activated and abrogated by proteolytic cleavage. We utilized species specificity and re-localization strategies to orthogonalize the cytokines and protease from the human context that they would be deployed in. hDIRECT should enable local cytokine activation to support a variety of cell-based therapies such as muscle regeneration and cancer immunotherapy. Our work offers a proof of concept for the emerging appreciation of humanization in synthetic biology for human health.

4 October 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AVAlexander E. Vlahos
Alexander E. Vlahos
CCConnor C. Call
Connor C. Call
SKSamarth E. Kadaba
Samarth E. Kadaba
SGSiqi Guo
Siqi Guo
XGXiaojing J. Gao
Xiaojing J. Gao
Synthetic biology currently holds immense potential to engineer the spatiotemporal control of intercellular signals for biomedicine. Programming behaviors using protein-based circuits has advantages over traditional gene circuits such as compact delivery and direct interactions with signaling proteins. Previously, we described a generalizable platform called RELEASE to enable the control of intercellular signaling through the proteolytic removal of ER-retention motifs compatible with pre-existing protease-based circuits. However, these tools lacked the ability to reliably program complex expression profiles and required numerous proteases, limiting delivery options. Here, we harness the recruitment and antagonistic behavior of endogenous 14-3-3 proteins to create RELEASE-NOT to turn off protein secretion in response to protease activity. By combining RELEASE and RELEASE-NOT, we establish a suite of protein-level processing and output modules called Compact RELEASE (compRELEASE). This innovation enables functions such as logic processing and analog signal filtering using a single input protease. Furthermore, we demonstrate the compactness of the post-translational design by using polycistronic single transcripts to engineer cells to control protein secretion via lentiviral integration and leverage mRNA delivery to selectively express cell surface proteins only in engineered cells harboring inducible proteases. CompRELEASE enables complex control of protein secretion and enhances the potential of synthetic protein circuits for therapeutic applications, while minimizing the overall genetic payload.

5 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
XZXiaowei Zhang
Xiaowei Zhang
LFLuis Santiago Mille Fragoso
Luis Santiago Mille Fragoso
KKK. Eerik Kaseniit
K. Eerik Kaseniit
CCConnor C. Call
Connor C. Call
MZMeng Zhang
Meng Zhang
XGXiaojing J. Gao
Xiaojing J. Gao
Inspired by the power of transcriptional synthetic receptors and hoping to complement them to expand the toolbox for cell engineering, we establish LIDAR (Ligand-Induced Dimerization Activating RNA editing), a modular post-transcriptional synthetic receptor platform that harnesses RNA editing by ADAR. LIDAR is compatible with various receptor architectures in different cellular contexts, and enables the sensing of diverse ligands and the production of functional outputs. Furthermore, LIDAR can sense orthogonal signals in the same cell and produce synthetic spatial patterns, potentially enabling the programming of complex multicellular behaviors. Finally, LIDAR is compatible with compact encoding and can be delivered as synthetic mRNA. Thus, LIDAR expands the family of synthetic receptors, holding the promise to empower basic research and therapeutic applications.

29 January 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
KKK. Eerik Kaseniit
K. Eerik Kaseniit
NKNoa Katz
Noa Katz
NKNatalie S. Kolber
Natalie S. Kolber
CCConnor C. Call
Connor C. Call
DWDiego L. Wengier
Diego L. Wengier
XGXiaojing J. Gao
Xiaojing J. Gao
With the increasing availability of single-cell transcriptomes, RNA signatures offer a promising basis for targeting living cells. Molecular RNA sensors would enable the study of and therapeutic interventions for specific cell types/stats in diverse contexts, particularly in human patients and non-model organisms. Here we describe a modular and programmable design for live R NA sensing using a denosine d eaminases a cting on R NA (RADAR). We validated and then expanded our basic design, characterized its performance, and thoroughly analyzed its compatibility with the human/mouse transcriptomes. We also identified strategies to further boost output levels and improve the dynamic range. We show that RADAR is programmable and modular, and uniquely enables compact AND logic. In addition to being quantitative, RADAR can distinguish disease-relevant point mutations. Finally, we demonstrate that RADAR is a self-contained system with the potential to function in diverse organisms.

7 August 2025 in bioRxiv
Verified
Preprint
Open access
TLTara N. Lowensohn
Tara N. Lowensohn
WCWill B. Cody
Will B. Cody
CTChun Tsai
Chun Tsai
AVAlexander E. Vlahos
Alexander E. Vlahos
CCConnor C. Call
Connor C. Call
ESElizabeth S. Sattely
Elizabeth S. Sattely
Genetic screens in whole plants are a powerful tool for functional genetics. However, elucidating gene function in highly redundant genetic programs such as signaling pathways remains challenging in both model and non-model plants. Here, we report a single-cell screening platform, PIVOT (Protoplast Isolation after Virus Overexpression in planTa ), to accelerate identification and functional characterization of plant genes. We used Nicotiana benthamiana as a heterologous host to test gene libraries arrayed in a single leaf. Two elements of our system made pooled screens possible in planta : (1) we harnessed viral superinfection exclusion to ensure single multiplicity of infection per cell during pooled library delivery, and (2) we engineered a cell surface protein as a phenotypic marker for isolating cells of interest from a heterogeneous population. Using this system, we recovered known and new regulators of cytokinin signaling from an Arabidopsis open reading frame library. We anticipate PIVOT will be broadly applicable for high-throughput, single-cell functional genetic screening across the plant kingdom.